Difference between revisions of "Part:BBa K4789002"
Sunny Duan (Talk | contribs) |
Sunny Duan (Talk | contribs) |
||
Line 17: | Line 17: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | <!-- --> | ||
+ | <!-- --> | ||
+ | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K4789002 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4789002 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
Latest revision as of 08:29, 6 October 2023
pre-miR-22
A growing number of studies highlights the role of miR-22 in cervical cancer drug resistance development [1-3]. Pre-miR-22 basic part was used to overexpress miR-22 in Hela cells.
Reference
[1] Nejati Kazem,Alivand MohammadReza,Arabzadeh AmirAhmad,MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.[J] .Pathol Res Pract, 2021, 223: 153452.
[2]Konishi Hiromi,Hayashi Masami,Taniguchi Kohei et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.[J] .Cancer Biol Ther, 2020, 21: 1128-1135.
[3]Zhang Lu,Chen Bin,Ding Ding,Decreased microRNA-22 is associated with poor prognosis in cervical cancer.[J] .Int J Clin Exp Pathol, 2017, 10: 9515-9520.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]